Search

Search Constraints

You searched for: Author/Creator Stensen, Signe

Search Results

1. Acute concomitant glucose‐dependent insulinotropic polypeptide receptor antagonism during glucagon‐like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity. Issue 9 (20th June 2022)

2. Dose‐dependent efficacy of the glucose‐dependent insulinotropic polypeptide (GIP) receptor antagonist GIP(3‐30)NH2 on GIP actions in humans. Issue 1 (1st October 2020)

3. Effects of endogenous GIP in patients with type 2 diabetes. Issue 1 (21st May 2021)

4. Factors associated with type‐specific persistence of high‐risk human papillomavirus infection: A population‐based study. Issue 2 (13th August 2015)

5. The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans. Issue 1 (10th January 2023)

6. The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans. Issue 1 (10th January 2023)

7. The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans. Issue 1 (10th January 2023)

8. The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans. Issue 1 (10th January 2023)